Second-generation antihistamines are the key to treating chronic urticaria, but other agents may be necessary to treat refractory disease


    loading  Checking for direct PDF access through Ovid

Abstract

The aim of management of chronic urticaria is to control the disease as much as possible, while minimizing the risk of adverse events. Second-generation histamine H1 receptor antagonists are the first-line treatment, with up to fourfold higher than licensed dosages being used if necessary. In patients with refractory disease, treatment with add-on leukotriene receptor antagonists and short courses of oral corticosteroids may be considered.

    loading  Loading Related Articles